Research summary, original research, 2026

Development and Effectiveness Evaluation of an Integrated Multidisciplinary Radiation Protection Management Framework for Tertiary Hospitals

Nian Y, Zhu H, Nian J. Health physics. 2026

Read the original paper

In plain language

At one Chinese tertiary hospital, a hospital-wide multidisciplinary radiation protection management program was followed by lower recorded staff doses and higher training and dosimetry compliance among 510 radiation workers, though the uncontrolled before-after design limits causal conclusions.

At a glance

Type of study
Original research, Retrospective cohort study
Who was studied
Mixed lab staff, Interventional radiologists, Interventional cardiologists
Size
n = 510 radiation workers
Where
China
Summary based on
the abstract

What it found

  • Average annual effective dose per worker fell after the framework was implemented.

    Key figures: 0.54 mSv to 0.34 mSv

  • Annual collective effective dose declined.

    Key figures: 212.66 to 133.12 person-mSv

  • Fewer workers received annual doses above 1 mSv.

    Key figures: 6.27% to 3.33% (P<0.001)

  • Training completion and certification rates rose.

    Key figures: training 81.57% to 98.63%; certification 90.39% to 100% (P<0.001)

  • Personal dosimetry monitoring became universal.

    Key figures: 92.75% to 100% (P<0.001)

Limits to keep in mind

Single-hospital retrospective before-after design with no control group, so secular trends or changes in workload or dosimetry compliance may explain part of the dose reduction; results are pooled across imaging, radiotherapy and interventional departments with no interventional-specific data in the abstract.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.